Clearside Biomedical, Inc. Files Registration Statement for Proposed Initial Public Offering

PRESS RELEASE: Clearside Biomedical, Inc., a late-stage clinical biopharmaceutical company developing innovative first-in-class drug therapies to treat blinding diseases of the eye, today announced that it has filed a registration statement on Form...